The imputation model (linear regression) was done separately for each treatment arm and included baseline value as a covariate and was fitted to all subjects with a measurement regardless of treatment status at Week 104
Three Key Takeaways: Symptom Improvement: Semaglutide significantly improves symptoms in both men and women with HFpEF
While AI promises efficiency, personalisation, and improves patient outcomes, there is still a gap in understanding how these technologies work, their limitations, and the ethical frameworks that must guide their use
For technique guidance, review injection best practices and injectable peptide protocols
Andres Fontaine Nicola MD Mario Masrur Francisco Schlottmann MD MPH Reed Berger MD, PNS, DABOM Amber Pirzada Khaled Abdelhady Bianca Serafica Lily Zhang To view or add a comment, sign in More Relevant Posts Drug Slows Kidney Deterioration in Non-Diabetic Patients